臨床試験を検索:ジペプチジルペプチダーゼ-4阻害剤 (DPP-4)
合計2580件
-
Novartis Pharmaceuticals完了
-
Novartis完了
-
The Affiliated Nanjing Drum Tower Hospital of Nanjing...募集
-
University of WashingtonNational Institute of Mental Health (NIMH)完了
-
Shinshu UniversityKowa Company, Ltd.募集T2DM(2型糖尿病) | メトホルミン | SGLT2阻害剤日本
-
Novartis完了
-
India Diabetes Research Foundation & Dr. A. Ramachandran...完了
-
Royal Devon and Exeter NHS Foundation TrustNovartis Pharmaceuticals; National Institute for Health Research, United Kingdom完了
-
Novartis Pharmaceuticals完了
-
National Cancer Institute (NCI)積極的、募集していない造血およびリンパ系細胞腫瘍 | 進行性リンパ腫 | 進行性悪性固形新生物 | 難治性リンパ腫 | 難治性悪性固形新生物 | 難治性多発性骨髄腫アメリカ
-
Royal Devon and Exeter NHS Foundation TrustNIHR Exeter Clinical Research Facility完了
-
Oslo University HospitalVestre Viken Hospital Trust; University of Oslo; The Research Council of Norway; University Hospital... と他の協力者募集
-
Novartis Pharmaceuticals完了
-
Rio de Janeiro State UniversityLaboratory for Clinical and Experimental Research on Vascular Biology完了
-
Mayo ClinicNovartis Pharmaceuticals完了
-
Johann Wolfgang Goethe University Hospital引きこもったSDF-1 は血管新生にとって重要なサイトカインです。 SDF-1の切断はDPPIV阻害剤によって減少しますドイツ
-
University Hospital, ToulouseNovartis Pharmaceuticals; Institute of Molecular Medicine of Rangueil (I2MR); Faculty of Medicine...完了
-
Maastricht UniversityNetherlands Brain Foundation完了
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)完了
-
Canadian Network for Observational Drug Effect...Canadian Institutes of Health Research (CIHR); Drug Safety and Effectiveness Network, Canada完了
-
Oasis Pharmaceuticals, LLCMayo Clinic; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)募集